WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EA Corticosteroids acting locally

Enemas and rectal foams for treatment of e.g. ulcerative colitis are classified here. Oral corticosteroids solely indicated for the treatment of intestinal inflammatory diseases are also classified here.
Sublingual formulations of budesonide for the treatment of eosinophilic esophagitis and oral formulations of budesonide for the treatment of primary immunoglobulin A nephropathy are classified in this group.

The DDDs are given as 1 enema. The DDD for hydrocortisone rectal foam is given in amount of active substance.
The DDD for oral budesonide is based on the treatment of morbus Crohn. The DDD for the subligual formulations of budesonide are based on the treatment of eosinophilic esophagitis.


    ATC code  Name  DDD  U Adm.R Note
    A07EA03 prednisone    

List of abbreviations

Last updated: 2024-01-26